Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Tracking Tumor-Targeting Nanoparticles in the Body

The behavior of targeted quantum dots (Qdots) across three different tumor models using intravital microscopy with submicrometer resolution is described. As in the figure, the differences in extravasation between tumor types are shown and the kinetics are quatnified. Further, by demonstrating similarity in Qdot binding to tumor blood vessels across different tumor types, this work suggests several advantages implicit in vascular targeting compared with tumor cell targeting.
The behavior of targeted quantum dots (Qdots) across three different tumor models using intravital microscopy with submicrometer resolution is described. As in the figure, the differences in extravasation between tumor types are shown and the kinetics are quatnified. Further, by demonstrating similarity in Qdot binding to tumor blood vessels across different tumor types, this work suggests several advantages implicit in vascular targeting compared with tumor cell targeting.

Abstract:
Though targeted nanoparticle-based imaging agents and therapeutics for diagnosing and treating cancer are making their way to and through the clinical trials process, researchers still do not have a good understanding of how nanoparticles reach tumors and how they then bind to and enter the targeted tumor. To overcome that knowledge deficit, two teams of investigators, both part of the Alliance for Nanotechnology in Cancer have undertaken studies aiming to track nanoparticles as they move through living animals.

Tracking Tumor-Targeting Nanoparticles in the Body

Bethesda, MD | Posted on October 27th, 2010

In one study, a team of investigators at Stanford University used quantum dots to study how nanoparticles travel through tumor blood vessels in living test subjects, bind to molecular targets on the surface of those blood vessels, and then travel out of the blood stream and into the tumor itself. Sanjiv Sam Gambhir, co-director of one of nine National Cancer Institute (NCI) Centers of Cancer Nanotechnology Excellence, led this study. He and his colleagues published their findings in the journal Small. In a second study, published in the journal ACS Nano, Alliance investigators Dong Shin, Mostafa El-Sayed, and Shuming Nie of Emory University and the Georgia Institute of Technology used targeted gold nanocrystals to study both active and passive targeting of tumors.

In the Stanford study, Dr. Gambhir and his collaborators exploited the capabilities of intravital microscopy, a technique that enables researchers to see brightly fluorescent markers through a living animal's skin in real time. In this series of experiments, the Stanford team examined nanoparticle trafficking in mice in which a variety of different types of tumors were allowed to grow in the animals' ears. For the fluorescent marker, the investigators used a near-infrared emitting quantum dot linked to RGD, a molecule known to bind tightly to a protein found on the surface of blood vessels surrounding tumors.

To their surprise, the researchers found that regardless of the type of tumor studied, nanoparticle binding only occurred when aggregates of particles - not single particles - were able to tether themselves to multiple, discreet sites within a tumor. The researchers were not able to detect any significant binding when they repeated these experiments using quantum dots lacking the RGD targeting molecule. The investigators also found that binding rates and binding patterns were consistent across all tumor types, a reassuring finding given the natural heterogeneity that characterizes human cancers.

While binding ability appears to be independent of tumor type, the same cannot be said for extravasation, i.e., the transit of a nanoparticle out of the blood stream and into a tumor. The researchers noted in their paper that it is likely that nanoparticle shape and size will play a critical role in determining how a given nanoparticle will extravasate into each particular type of tumor.

Meanwhile, the Emory-Georgia Tech team used rod-shaped gold nanocrystals linked to tumor-targeting peptides to explore the delivery mechanisms that enable nanoparticles to accumulate in tumors. The investigators used gold nanoparticles so that they could quantify the number of nanoparticles reaching tumors and other tissues. Gold does not occur naturally in mammals, so any gold detected in a given tumor or tissue using the highly sensitive and accurate technique known as elemental mass spectrometry would had to have come from gold nanoparticles.

To conduct their experiments, the investigators created three formulations by attaching one of three tumor-targeting molecules to the surface of the gold nanorods. They then injected the nanoparticles into animals bearing implanted human tumors, allowed the nanoparticles to circulate through the body, and measured the amount of gold that accumulated in the implanted tumors and other tissues. The researchers also repeated this experiment using untargeted gold nanoparticles. The results were surprising in that the targeting molecules only marginally increased the amount of gold that accumulated in tumors.

The investigators concluded that gold nanoparticles designed to be used in photothermal anticancer therapy should be injected directly into tumors rather than via intravenous administration in order to achieve the greatest concentration of gold in tumors. They also noted in their paper that these experiments suggest that target binding is not the rate limiting step for nanoparticle delivery, but rather that transport out of the blood stream and into tumors is the major barrier to nanoparticle accumulation in tumors.

The work using intravital microscopy, which is detailed in a paper titled, "Dynamic Visualization of RGD-Quantum Dot Binding to Tumor Neovasculature and Extravasation in Multiple Living Mouse Models Using Intravital Microscopy," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. An abstract of this paper is available at the journal's website.

View Abstract at dx.doi.org/doi:10.1002/smll.201001022

The work using gold nanocrystals, which is detailed in a paper titled, "A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Targeted Peptide Ligands," was also supported in part by the NCI Alliance for Nanotechnology in Cancer. An abstract of this paper is available at the journal's website.

View abstract at pubs.acs.org/doi/abs/10.1021/nn102055s

####

About NCI Alliance for Nanotechnology in Cancer
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Copyright © NCI Alliance for Nanotechnology in Cancer

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Leti Presents Advances in Propagation Modeling and Antenna Design for mmWave Spectrum: Paper Is One of 15 that Leti Presented at European Conference on Antennas and Propagation March 19-24 March 23rd, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Govt.-Legislation/Regulation/Funding/Policy

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Academic/Education

AIM Photonics Welcomes Coventor as Newest Member: US-Backed Initiative Taps Process Modeling Specialist to Enable Manufacturing of High-Yield, High-Performance Integrated Photonic Designs March 16th, 2017

Nominations Invited for $250,000 Kabiller Prize in Nanoscience: Major international prize recognizes a visionary nanotechnology researcher February 20th, 2017

Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Nanomedicine

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Nanoparticle paves the way for new triple negative breast cancer drug March 20th, 2017

Block copolymer micellization as a protection strategy for DNA origami March 17th, 2017

Nanocages for gold particles: what is happening inside? March 16th, 2017

Announcements

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Quantum Dots/Rods

Particle Works creates range of high performance quantum dots February 23rd, 2017

Strem Chemicals and Dotz Nano Ltd. Sign Distribution Agreement for Graphene Quantum Dots Collaboration February 21st, 2017

Carbon dots dash toward 'green' recycling role: Rice scientists, colleagues use doped graphene quantum dots to reduce carbon dioxide to fuel December 18th, 2016

Two electrons go on a quantum walk and end up in a qudit: Russian scientists find a way to reliably connect quantum elements December 13th, 2016

Nanobiotechnology

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Nanoparticle paves the way for new triple negative breast cancer drug March 20th, 2017

Block copolymer micellization as a protection strategy for DNA origami March 17th, 2017

Nanocages for gold particles: what is happening inside? March 16th, 2017

Research partnerships

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Rice U. refines filters for greener natural gas: New study defines best materials for carbon capture, methane selectivity March 23rd, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Pulverizing e-waste is green, clean -- and cold: Rice, Indian Institute researchers use cryo-mill to turn circuit boards into separated powders March 21st, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project